Court Backs Drug Cos. In Suicide Cases

Law360, New York (April 9, 2008, 12:00 AM EDT) -- The U.S. Court of Appeals for the Third Circuit has ruled that federal guidelines on drug warning labels trump state law in a case involving two people who committed suicide while taking antidepressants.

The families of the deceased sued GlaxoSmithKline and Pfizer under state failure-to-warn laws. Warning labels on Paxil and Zoloft did not include strong enough warnings about the risk of suicide and worsening depression, they said.

In a 2-1 decision, the appeals court rejected that argument Tuesday. It ruled that the drugmakers could not...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.